Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06799117

Adaptive Decision Support for Addiction Treatment (ADAPT)

Led by Yale University · Updated on 2025-06-25

1912

Participants Needed

3

Research Sites

N/A

Total Duration

On this page

Sponsors

Y

Yale University

Lead Sponsor

N

National Institute on Drug Abuse (NIDA)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are refining and optimizing the EMBED clinical decision support system to help emergency department (ED) physicians better follow guidelines for giving buprenorphine to patients with opioid use disorder (OUD). This study uses a Multiphase Optimization Strategy (MOST) with preparation, optimization, and confirmation phases to improve how the system supports treatment initiation in emergency care. The goal is to increase the number of physicians using the standard of care for buprenorphine administration in appropriate patients. The study has multiple phases. In the first optimization stage, a 2x2x2 factorial trial tests adding sustainable strategies like nurse prompts for withdrawal assessment, targeted clinician prompts to use the decision support system, and patient resources to promote equity and readiness for treatment. The second stage involves rapid serial randomized testing to improve system usability and reduce errors by refining the interface and workflow. The evaluation phase compares the optimized system to the original in a randomized trial focused on rates of buprenorphine initiation in the ED. Participants are emergency department patients aged 18 or older with moderate to severe opioid use disorder. Researchers will monitor the proportion of patient encounters where buprenorphine is started and assess engagement with the clinical decision support system. The study tracks outcomes from the ED visit through the end of each trial phase, which may last up to 18 months. The system integrates diagnosis, withdrawal severity assessment, patient motivation techniques, and automates clinical workflow including documentation and referrals.

CONDITIONS

Brief Title

Adaptive Decision Support for Addiction Treatment Master

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Emergency department patient
  • 18 years of age or older
  • Moderate to severe opioid use disorder
Not Eligible

You will not qualify if you...

  • Under 18 years of age
  • Pregnant
  • Currently receiving medication for opioid use disorder

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Optimization Phase, Stage 1: Factorial Trial

Duration - Up to 18 months

Participants experience the EMBED clinical decision support system with various implementation strategies including nurse prompts, clinician prompts, and patient-facing materials to support initiation of buprenorphine treatment in the emergency department.

Visits occur during emergency department encounters as needed

Optimization Phase, Stage 2: Rapid serialized testing

Duration - Variable, within the trial period

Participants undergo iterative testing of refinements to the EMBED system interface and workflow to improve usability and reduce errors based on user feedback.

Visits occur during emergency department encounters as needed

Evaluation Phase

Duration - Up to 18 months

Participants are randomized to receive either the optimized EMBED system or the original EMBED system to compare effectiveness on buprenorphine initiation rates during emergency department visits.

Visits during emergency department encounters as part of routine care

Trial Site Locations

Total: 3 locations

1

Yale New Haven Shoreline Medical Center

Guilford, Connecticut, United States, 06437

Actively Recruiting

2

Yale New Haven Hospital- St. Raphael

New Haven, Connecticut, United States, 06510

Actively Recruiting

3

Yale New Haven Hospital

New Haven, Connecticut, United States, 06510

Actively Recruiting

Loading map...

Research Team

E

Edward Melnick, MD, MHS

L

Laurel Buchanan

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Similar Trials

A Bundled Intervention to End Opioid Overdose by Increasing ...

Opioid Use Disorder

Actively Recruiting

1 location

A Randomized Controlled Trial Examining Extended-Release Inj...

Opioid Use Disorder

Actively Recruiting

1 location

Comparative Effectiveness of Injectable Versus Daily Oral Bu...

Opioid Use Disorder

Actively Recruiting

25 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial.

Mark S Iscoe, Carolina Diniz Hooper, Deborah R Levy...

https://pubmed.ncbi.nlm.nih.gov/39979056